Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB)

2 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q4 2023.
Y-mAbs Therapeutics, Inc. - Common stock, par value $0.0001 per share (YMAB) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.6K shares of 45.1M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.92M shares), VANGUARD GROUP INC (2.24M shares), Sofinnova Investments, Inc. (2.19M shares), Polar Capital Holdings Plc (2.06M shares), D. E. Shaw & Co., Inc. (1.32M shares), Caligan Partners LP (1.05M shares), ACADIAN ASSET MANAGEMENT LLC (802K shares), STATE STREET CORP (762K shares), GEODE CAPITAL MANAGEMENT, LLC (739K shares), and BOOTHBAY FUND MANAGEMENT, LLC (694K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.